Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,100 | -19,928 | -72,891 | -41,481 | -23,754 |
| Accounts payable and accrued liabilities | 828 | -651 | 725 | 350 | 41 |
| Other Working Capital | 4,486 | -1,255 | -1,828 | -919 | -2,682 |
| Other Operating Activity | 2,901 | 2,740 | 5,549 | 3,843 | 2,446 |
| Operating Cash Flow | $-35,885 | $-19,094 | $-68,445 | $-38,207 | $-23,949 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -194,029 | -126,231 | 135,077 | 137,077 | 137,077 |
| PPE Investments | -305 | N/A | -25 | -9 | -5 |
| Investing Cash Flow | $-194,334 | $-126,231 | $135,052 | $137,068 | $137,072 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 141,901 | 141,807 | 88,398 | 420 | 310 |
| Financing Cash Flow | $141,901 | $141,807 | $88,398 | $420 | $310 |
| Beginning Cash Position | 175,693 | 175,693 | 20,688 | 20,688 | 20,688 |
| End Cash Position | 87,375 | 172,175 | 175,693 | 119,969 | 134,121 |
| Net Cash Flow | $-88,318 | $-3,518 | $155,005 | $99,281 | $113,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,885 | -19,094 | -68,445 | -38,207 | -23,949 |
| Capital Expenditure | -305 | N/A | -25 | -9 | -5 |
| Free Cash Flow | -36,190 | -19,094 | -68,470 | -38,216 | -23,954 |